Single-Agent Mosunetuzumab Shows Durable Complete Responses in Patients With Relapsed or Refractory B-Cell Lymphomas: Phase I Dose-Escalation Study ...
To search for a full-text article published before 1997, see PubMed Central. To view themed issues and supplements, see Supplements.
GuardDog is a CLI tool that allows to identify malicious PyPI and npm packages, Go modules, GitHub actions, or VSCode extensions. It runs a set of heuristics on the package source code (through ...
Objectives: The ARMANI trial demonstrated that ramucirumab plus paclitaxel (switch maintenance group) significantly prolonged progression-free survival (PFS) and overall survival in patients with ...
e203的取指单元主要分为两部分，e203_ifu_ifetch实现了PC，IR寄存器，并将其和之前叙述的minidec与litebpu结合起来，组成了取指控制电路；而另一部分即e203_ifu_ift2icb则专门负责管理对指令存储器的访问。 下图描述了e203_ifu_ifetch相关的模块例化关系。
Durvalumab concurrent with chemoradiotherapy was well tolerated in participants with locally advanced cervical cancer, however it did not significantly improve progression-free survival in a biomarker ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback